产品介绍：
产品说明
应用
MEGX has been used in an approach to improve the yield of N-dealkylated lidocaine.
包装
5, 25 mg in glass bottle
生化/生理作用
Monoethylglycinexylidide (MEGX) is an active metabolite of lidocaine.
MEGX is generated by hepatic cytochrome P-450 system upon oxidative de-ethylation. Measurement of MEGX by immunoassay contributes to liver function test. MEGX possesses antiarrhythmic action and therefore extends lidocaine effect.
基本信息
| 经验(实验)分子式 | C12H18N2O |
| 分子量 | 206.28 |
| MDL编号 | MFCD00098991 |
| PubChem化学物质编号 | 329825147 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥95% (HPLC) |
| 形式 | powder |
| 储存条件 | desiccated |
| 颜色 | white to beige |
| 溶解性 | H2O: 10 mg/mL, clear |
| 储存温度 | 2-8℃ |
| SMILES string | CC1=C(NC(CNCC)=O)C(C)=CC=C1 |
| InChI | 1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15) |
| InChI key | WRMRXPASUROZGT-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Danger |
| 危险声明 | H301 |
| 预防措施声明 | P301 + P310 |
| 危险分类 | Acute Tox. 3 Oral |
| 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
